Neosoma, a best-in-class provider of AI-based brain tumor analysis medical software, receives FDA 510(k) clearance for its Brain Mets product. This clearance ushers in a new era in the assessment of ...
A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers ...
7don MSNOpinion
Kentucky can lead the nation in the next revolution of early cancer detection | Opinion
OpEd: Multicancer early detection is the next frontier in cancer prevention and treatment, and it needs to be adopted widely.
The CATNON trial showed adjuvant Temodar benefits grade 3 glioma patients, with no added benefit from concurrent chemotherapy, reducing potential toxicity. HER3-DXd, an antibody-drug conjugate, ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
While earlier detection improves outcomes, it does not reduce costs. Cancer treatment typically involves repeated ...
Childhood cancers are relatively rare compared to adult cancers, but they remain a significant health concern because they often develop suddenly and progress quickly. Mostly, childhood cancers – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback